Skip to main content
. 2021 Feb 23;94(3):854–883. doi: 10.1111/papt.12332

Table 2.

Between group differences in working alliance, primary outcomes, dropout, and satisfaction in large randomized controlled trials involving direct comparisons with in‐person therapy

Study Population N Therapy Therapeutic alliance Primary outcome Dropout/satisfaction
Acierno et al. (2016) PTSD and depression, veterans 232 BA‐TE

PCL‐M, BDI: VC non‐inferior to IP at post‐therapy, and 3 and 12 months

Rate of completion of both therapy and post‐treatment assessment: no difference (VC 82%, IP 77%)
Acierno et al. (2017), Gros, Allan, et al. (2018) PTSD and depression, veterans 150 PE

PCL‐M: VC non‐inferior to IP at post‐therapy, 3 months and 6 months;

BDI: VC non‐inferior to IP at 6 months, inconclusive at post and 3 months

No difference in number of sessions attended (VC 7.6, IP 8.6) or completion of a minimum dose of 6 sessions, but discontinuation occurred earlier in VC over sessions 1‐8
Liu et al. (2019) PTSD, veterans 207 CPT CAPS: VC non‐inferior to IP at 6 months, but not at post‐therapy; PCL: VC non‐inferior to IP at post and 6 months. PHQ‐9: VC non‐inferior to IP at post and 6 months No difference in study dropout (VC 23%, IP 28%)
Maieritsch et al. (2016) PTSD, veterans 90 CPT WAI client ratings show equivalence CAPS, PCL: inconclusive but trend for equivalence between groups (p < .10) High rates of treatment dropout (43% overall) but no difference by group
Morland et al. (2015) PTSD, female, civilians and veterans 149 CPT WAI client ratings: VC inferior to IP at session 2, but difference small (d = −0.07), and no difference at session 6 or 12; therapist ratings: no difference at any time point. Homework completion: no difference (VC 77%, IP 80%) CAPS: VC non‐inferior to IP at post‐treatment, 3 and 6 months.

Therapy completion rate: no difference (≥ 10 sessions: VC 76%, IP 79%). Treatment expectations: no difference.

Satisfaction ratings: both groups rated service highly on global ratings, with no difference, but VC inferior to IP on CPOSS ratings of broader service delivery (d = −0.24)

Yuen et al. (2015) PTSD, combat‐related 52 PE No difference on ratings of how comfortable feel talking with therapist or quality of communication CAPS: VC non‐inferior to IP; PCL: neither group superior but non‐inferiority analysis inconclusive SDPQ: 100% satisfied with treatment in both VC and IP
Choi, Hegel, et al. (2014), Choi, Marti, et al. (2014) Depression, housebound adults over 50 158 PST HAMD: neither group superior at 12 or 24 weeks; VC superior to IP at 36 weeks; WHODAS: neither superior at any time point Treatment Evaluation Inventory: VC superior to IP
Egede et al. (2015) Depression, veterans 241 BA BDI, GDS, SCID: VC non‐inferior at 4 weeks (mid), 8 weeks (post) and 3 months. No difference in full therapy completion rate (VC 81%, IP 79%)
Luxton et al. (2016) Depression, military personnel 121 BA BDI: VC non‐inferior to IP at mid‐therapy and 12 weeks, but not at post‐therapy; BHS: VC non‐inferiority not established at any time point, and found to be inferior to IP at post‐therapy.

CSQ: high satisfaction, no difference between groups.

Attitudes to seeking mental health treatment: no difference between groups. No difference in full therapy completion rate (VC 64%, IP 71%)

Watts et al. (2020) Generalized anxiety disorder 115 CBT WAI: Across 8 time points, VC superior to IP in client ratings; neither group superior on therapists’ ratings.
Mitchell et al. (2008), Ertelt et al. (2011), Marrone et al. (2009) Bulimia nervosa or EDNOS 128 CBT

WAI: no difference in client ratings, VC inferior to IP in therapist ratings.

EDE: neither group superior for abstinence from bingeing and/or purging. VC inferior to IP for reduction in binge eating frequency across time points. Client ratings of treatment suitability, client expectation of success, and number of sessions completed: no difference.
Morgan et al. (2008) People in prison or secure forensic psychiatric hospital 186 Individualized therapy WAI: no difference in client ratings. No differences on CSQ, or ratings of session depth, smoothness, positivity or distress.

Only includes randomized controlled trials sufficiently powered to detect large between group effects (N ≥ 52 at 80% power). If no primary outcome specified, symptoms of target disorder listed. Superiority/inferiority refers to group differences observed versus a null hypothesis of no difference; non‐inferiority (one tailed test) and equivalence (two‐tailed test) refer to whether or not the confidence interval for the difference includes a null hypothesis of the groups differing by the minimum clinically significant difference. PTSD = post‐traumatic stress disorder; EDNOS = Eating disorder not otherwise specified. Therapies: BA = behavioural activation; BA‐TE = behavioural activation and therapeutic exposure; CBT = cognitive behavioural therapy; CPT = cognitive processing therapy; PST = problem‐solving therapy. Groups: IP = in‐person; VC = videoconferencing. Measures: BDI = Beck Depression Inventory; CAPS = Clinician Administered PTSD Scale; CGI = Clinical Global Impression; CPOSS = Charleston Psychiatric Outpatient Satisfaction Scale; CSQ = Client Satisfaction Questionnaire; EDE = Eating Disorders Examination; GDS = Geriatric Depression Scale; HAMD = Hamilton Rating Scale for Depression; SCID = Structured Clinical Interview for DSM diagnosis; SCL‐90R = Hopkins Symptom Checklist; SDPQ = Service Delivery Perceptions Questionnaire; SEQ = Session Evaluation Questionnaire; WAI = Working Alliance Inventory.